Phreesia, Inc.

NYSE:PHR 株式レポート

時価総額:US$1.1b

Phreesia マネジメント

マネジメント 基準チェック /24

Phreesiaの CEO はChaim Indigで、 Jan2005年に任命され、 の在任期間は 19.83年です。 の年間総報酬は$ 8.27Mで、 6%給与と94%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の2.25%を直接所有しており、その価値は$ 24.06M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と17.1年です。

主要情報

Chaim Indig

最高経営責任者

US$8.3m

報酬総額

CEO給与比率6.0%
CEO在任期間19.8yrs
CEOの所有権2.2%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間17.1yrs

経営陣の近況

Recent updates

Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues

Nov 07
Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues

Is Phreesia (NYSE:PHR) Weighed On By Its Debt Load?

Oct 08
Is Phreesia (NYSE:PHR) Weighed On By Its Debt Load?

Here's What Analysts Are Forecasting For Phreesia, Inc. (NYSE:PHR) After Its Second-Quarter Results

Sep 06
Here's What Analysts Are Forecasting For Phreesia, Inc. (NYSE:PHR) After Its Second-Quarter Results

Phreesia: Remain Bullish Given The Healthy Growth Outlook

Sep 05

Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues Pushing Shares 26% Higher

Jul 18
Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues Pushing Shares 26% Higher

Phreesia: Growth Remains Strong, With EBITDA Margin Set To Improve

Jun 06

The Price Is Right For Phreesia, Inc. (NYSE:PHR)

May 25
The Price Is Right For Phreesia, Inc. (NYSE:PHR)

Are Investors Undervaluing Phreesia, Inc. (NYSE:PHR) By 39%?

May 03
Are Investors Undervaluing Phreesia, Inc. (NYSE:PHR) By 39%?

At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?

Apr 12
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?

Phreesia Continues To Stay Positive On The Business Growth

Apr 03

Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation

Mar 01

Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)

Feb 16
Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)

Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth

Jan 04

Is Phreesia Finally Turning The Corner?

Dec 07

Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?

Oct 25
Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?

Phreesia: Share Price Dip Is A Buying Opportunity

Sep 21

Phreesia: Strong Execution Should Continue To Drive Growth

Jul 11

Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion

May 18
Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion

Phreesia: Strong Growth Momentum With Expanded TAM

Jan 28

Phreesia - Healthcare Ecosystem At An Attractive Valuation

Dec 13

Phreesia Q3 2023 Earnings Preview

Dec 07

Phreesia GAAP EPS of -$0.89 beats by $0.08, revenue of $67.9M beats by $2.15M

Sep 07

Phreesia: Their Time Has Passed

May 10

Opportunistic Time To Buy Phreesia's Healthcare Disruption

Dec 27

CEO報酬分析

Phreesia の収益と比較して、Chaim Indig の報酬はどのように変化したか?
日付総報酬給与会社業績
Jul 31 2024n/an/a

-US$100m

Apr 30 2024n/an/a

-US$119m

Jan 31 2024US$8mUS$495k

-US$137m

Oct 31 2023n/an/a

-US$144m

Jul 31 2023n/an/a

-US$152m

Apr 30 2023n/an/a

-US$162m

Jan 31 2023US$8mUS$515k

-US$176m

Oct 31 2022n/an/a

-US$185m

Jul 31 2022n/an/a

-US$181m

Apr 30 2022n/an/a

-US$158m

Jan 31 2022US$9mUS$515k

-US$118m

Oct 31 2021n/an/a

-US$80m

Jul 31 2021n/an/a

-US$50m

Apr 30 2021n/an/a

-US$32m

Jan 31 2021US$6mUS$419k

-US$27m

Oct 31 2020n/an/a

-US$23m

Jul 31 2020n/an/a

-US$19m

Apr 30 2020n/an/a

-US$83m

Jan 31 2020US$10mUS$346k

-US$91m

Oct 31 2019n/an/a

-US$102m

Jul 31 2019n/an/a

-US$113m

Apr 30 2019n/an/a

-US$54m

Jan 31 2019US$510kUS$300k

-US$45m

報酬と市場: Chaimの 総報酬 ($USD 8.27M ) は、 US市場 ($USD 3.21M ) の同規模の企業の平均を上回っています。

報酬と収益: Chaimの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Chaim Indig (44 yo)

19.8yrs

在職期間

US$8,273,307

報酬

Mr. Chaim Indig co-founded Phreesia, Inc. in January 2005 and serves as Chief Executive Officer and Director since January 2005. Mr. Indig has helped to revolutionize the patient check-in experience. Under...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Chaim Indig
Co-Founder19.8yrsUS$8.27m2.25%
$ 24.1m
Evan Roberts
Co-Founder & COO19.8yrsUS$4.50m1.3%
$ 14.0m
Balaji Gandhi
Chief Financial Officer1.7yrsUS$5.91m0.17%
$ 1.8m
Allison Hoffman
General Counsel & Secretary4.3yrsUS$3.04m0.082%
$ 877.5k
David Linetsky
Senior Vice President of Life Sciences5.7yrsUS$4.47m0.36%
$ 3.9m
Yvonne Hui
VP & Principal Accounting Officerless than a yearデータなしデータなし
Jack Callahan
Chief Technology Officerless than a yearデータなしデータなし
Maureen McKinney
Vice President of Corporate Communications3.8yrsデータなしデータなし
Ashwin Uttamchandani
Vice President of Sales & Marketing Operationsno dataデータなしデータなし
Amy VanDuyn
Senior Vice President of Human Resources14.6yrsデータなし0.21%
$ 2.2m
Hilary Hatch
Chief Clinical Officer3.6yrsデータなしデータなし
Melissa Mitchell
Chief Privacy Officer1.4yrsデータなしデータなし

3.8yrs

平均在職期間

44yo

平均年齢

経験豊富な経営陣: PHRの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Chaim Indig
Co-Founder19.8yrsUS$8.27m2.25%
$ 24.1m
Eve Kurtin
Board Observerno dataデータなしデータなし
Edward Cahill
Independent Director17.1yrsUS$232.46k0.065%
$ 696.3k
Michael Weintraub
Independent Chairman19.8yrsUS$384.98k0.57%
$ 6.2m
Richard Jackson
Member of Medical Advisory Boardno dataデータなしデータなし
Gillian Munson
Independent Director5.5yrsUS$257.46k0.018%
$ 189.2k
Elsa-Grace Giardina
Member of Medical Advisory Boardno dataデータなしデータなし
Mark Blais
Member of Medical Advisory Boardno dataデータなしデータなし
Michael Brodman
Member of Medical Advisory Boardno dataデータなしデータなし
Lee Schwamm
Member of Medical Advisory Boardno dataデータなしデータなし
Susan MacDonald
Member of Medical Advisory Boardno dataデータなしデータなし
Mark Smith
Independent Director6.1yrsUS$244.98k0.011%
$ 113.2k

17.1yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: PHRの 取締役会 は経験豊富で 経験豊富 です ( 17.1年の平均在任期間)。